We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF
SBIO

66 hedge funds and large institutions have $74.8M invested in ALPS Medical Breakthroughs ETF in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

203% more call options, than puts

Call options by funds: $1.57M | Put options by funds: $519K

50% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 14

1.81% more ownership

Funds ownership: 30.88% → 32.69% (+1.8%)

5% less capital invested

Capital invested by funds: $79M → $74.8M (-$4.18M)

6% less funds holding

Funds holding: 70 → 66 (-4)

31% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 13

Holders
66
Holders Change
-4
Holders Change %
-5.71%
% of All Funds
1.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
21
Reduced
14
Closed
13
Calls
$1.57M
Puts
$519K
Net Calls
+$1.05M
Net Calls Change
-$985K

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$1.91M
2
Citadel Advisors
Citadel Advisors
Florida
+$1.52M
3
Morgan Stanley
Morgan Stanley
New York
+$644K
4
FTUS
Flow Traders U.S.
New York
+$583K
5
BPA
Beacon Pointe Advisors
California
+$417K

Top Sellers

Rank Fund Capital Flow
1
WIA
Wealthstreet Investment Advisors
Texas
-$1.64M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1.56M
3
FEM
Fulcrum Equity Management
Texas
-$1.24M
4
Osaic Holdings
Osaic Holdings
Arizona
-$749K
5
UBS Group
UBS Group
Switzerland
-$548K
Name Holding Trade Value Shares
Change 		Change in
Stake
EWA
26
Exencial Wealth Advisors
Oklahoma
$428K +$110K +2,287 +35%
BPA
27
Beacon Pointe Advisors
California
$426K +$417K +8,700 New
MC
28
Matisse Capital
Oregon
$369K +$4.98K +104 +1%
SWP
29
Stratos Wealth Partners
Ohio
$300K +$20.1K +420 +7%
CCC
30
Crescent Capital Consulting
Louisiana
$293K – – –
CT
31
Cambridge Trust
Massachusetts
$250K -$296K -6,171 -55%
UCFA
32
United Capital Financial Advisors
Texas
$249K +$9.58K +200 +4%
VNA
33
Valley National Advisers
Pennsylvania
$210K -$8.96K -187 -4%
KFGK
34
Keystone Financial Group (Kentucky)
Kentucky
$201K – – –
AWM
35
AllSquare Wealth Management
New York
$155K -$27.5K -575 -15%
Northwestern Mutual Wealth Management
36
Northwestern Mutual Wealth Management
Wisconsin
$98K +$15.6K +326 +19%
KPCM
37
Kings Point Capital Management
New York
$78K – – –
EWM
38
Elmwood Wealth Management
California
$49K – – –
US Bancorp
39
US Bancorp
Minnesota
$49K – – –
ASN
40
Advisory Services Network
Georgia
$42K +$40.7K +850 New
JP Morgan Chase
41
JP Morgan Chase
New York
$29K +$4.31K +90 +18%
S
42
SignatureFD
Georgia
$20K – – –
MCM
43
MV Capital Management
Maryland
$20K +$19.2K +400 New
First Manhattan
44
First Manhattan
New York
$19K +$4.79K +100 +33%
LWANC
45
Laurel Wealth Advisors (North Carolina)
North Carolina
$18K – – –
CFD
46
Creative Financial Designs
Indiana
$17K -$19.2K -400 -53%
APA
47
American Portfolios Advisors
New York
$16.7K -$5.99K -125 -27%
OC
48
Oakworth Capital
Alabama
$15K – – –
TWM
49
Tradition Wealth Management
Minnesota
$15K – – –
FHC
50
First Horizon Corporation
Tennessee
$14K +$14.6K +305 New
1
2
3 4

SBIO Hedge Fund Activity: Q2 2021 in Review

66 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q2 2021, worth a combined $74.8M — down 5.3% from $79M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of SBIO and 9 opened new positions — a net loss of 4 holders — while 14 trimmed existing stakes and 21 added.

The largest buyer was Tower Research Capital (TRC), adding an estimated $1.91M. The largest seller was Wealthstreet Investment Advisors, exiting entirely with an estimated $1.64M sold.

  • 66 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q2 2021, down from 70 in Q1 2021.
  • Funds reported $74.8M of ALPS Medical Breakthroughs ETF stock for Q2 2021, down 5.3% quarter-over-quarter.
  • 9 funds opened new ALPS Medical Breakthroughs ETF positions in Q2 2021 and 13 closed out, a net change of -4 holders.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q2 2021 was Tower Research Capital (TRC), an estimated $1.91M added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q2 2021 was Wealthstreet Investment Advisors, an estimated $1.64M sold.

Based on aggregated 13F filings for Q2 2021.